Epstein-Barr virus and wild p53 in idiopathic pulmonary fibrosis

Respiratory Medicine

Volumn 95, Issue 10, 2001, Pages 787-791

  Lok, S S ^a   Stewart, J P ^b   Kelly, B G ^b   Hasleton, P S ^a   Egan, J J ^a  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Epstein Barr virus; Idiopathic pulmonary fibrosis; p53

Indexed keywords

PROTEIN P53;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; IMMUNOHISTOCHEMISTRY; LUNG BIOPSY; LUNG FIBROSIS; LUNG PARENCHYMA; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034752512     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1053/rmed.2001.1152     Document Type: Article

References (24)

1. Interstitial disease of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract
2. p53 expression during normal tissue regeneration in response to acute cutaneous injury in swine
3. Re-population of denuded tracheal grafts with normal, pre-neoplastic and neoplastic epithelial cell populations
4. Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis
5. WafI/CipI/SdiII and p53 expression in assocation with DNA strand breaks in idiopathic pulmonary fibrosis
6. Epstein-Barr Virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis
7. The detection of Epstein-Barr virus DNA in lung tissue from idiopathic pulmonary fibrosis patients
8. Cryptogenic fibrosing alveolitis: Lack of association with Epstein-Barr virus infection
9. Functional and physical interaction between p53 and BZLFI: Implications for Epstein Barr virus latency
10. The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis
11. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-I
12. The use of lymphomatous and lymphoblastoid cell lines in the study of Burkitt's lymphoma
13. p53 mutations in human lymphoid malignacies: Association with Burkitt's lymphoma and chronic lymphocytic leukaemia
14. Detection of EBV DNA in post-nasal space biopsy tissue from asymptomatic EBV-seropostive individuals
15. p53: Puzzle and paradigm
16. EBNA-5, an Epstein Barr virus encoded nuclear antigen, binds to the retinoblastoma and p53 proteins
17. Human oropharyngeal lesions with a defective Epstein Barr Virus that disrupts viral latency
18. Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: Aneuploidy and immortilization
19. Role of mesenchymal cell death in lung remodelling after injury
20. The E6 oncoprotein encoded by human papilloma virus type 16 and 18 promotes degradation of p53
21. Associations among telomerase activity, p53 protein overexpression, and genetic instability in lung cancer
22. Expression of p53, p21 (WafI/CipI/SdiI) and Fas antigen in collagen vascular disease and granulomatous lung diseases
23. Promotion of IL8, IL10, TNFα and TNFβ production by EBV infection
24. Bleomycin mediated pulmonary toxicity: Evidence for a p53-medited response